Alex

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

Wipro Appoints Sanjeev Jain as Chief Operating Officer

EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)--$WIPRO #AIprinciples--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO),…

Cleaver-Brooks Acquired by Miura Co., Ltd.

THOMASVILLE, Ga.--(BUSINESS WIRE)--Cleaver-Brooks announces that it has been acquired by Miura Co., Ltd., a leading…

Brenmiller’s Project Pipeline Expands to 49 Projects Representing Over $500 Million in Potential Value in 12 Industries Across 13 Countries

Contract proposals and negotiations with some of the world’s largest companies, including Fortune 100s, demonstrate…

Ryde Supercharges Mobility with AI-Driven App Revamp

SINGAPORE--(BUSINESS WIRE)--Ryde Group Ltd (“Ryde” or “the Company”) (NYSE American: RYDE), a leading technology company…

Verdantis Appoints Kumar Gaurav Gupta as Chief Executive Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of…

SK hynix and HLDS Jointly Developed Tube T31 and Haechi H02 Win Red Dot Design Award and Exhibit at COMPUTEX

SEOUL, South Korea--(BUSINESS WIRE)--Leading semiconductor company SK hynix today announced that its stick-type SSD, the…

NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+

LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic…

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA)…